Arcadia Biosciences Inc (NASDAQ:RKDA) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Stan Jacot - President and Executive Officer Pam Haley - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Dipesh Patel - H.C. Wainwright Operator Good afternoon, and welcome to the Arcadia Biosciences Third Quarter 2022 Earnings Conference Call. Today's presenters will be Stan Jacot, President and Chief Executive Officer; and Pam Haley, Chief F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37383 Arcadia Biosciences, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 81-0571538 (State or other ju ...

Arcadia Biosciences Inc (NASDAQ:RKDA) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Stan Jacot - President and Executive Officer Pam Haley - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Brian Wright - ROTH Capital Partners Operator Good afternoon, and welcome to the Arcadia Biosciences Second Quarter 2022 Earnings Conference Call. Today's presenters will be Stan Jacot, President and Executive Officer; and Pam Haley, Chief Fi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37383 Arcadia Biosciences, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 81-0571538 (State or other jurisdi ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Stan Jacot - President and Chief Executive Officer Pam Haley - Chief Financial Officer Conference Call Participants Benjamin Klieve - Lake Street Capital Markets Operator Good afternoon. And welcome to Arcadia Biosciences First Quarter 2022 Earnings Conference Call. Today’s presenters will be Stan Jacot, President and Chief Executive Officer; and Pam Haley, Chief Financial Officer of Arcadia ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37383 Arcadia Biosciences, Inc. (Exact Name of Registrant as Specified in its Charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 (I.R.S. Employer Identification No.) Regis ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37383 Arcadia Biosciences, Inc. (Exact name of Registrant as specified in its Charter) Delaware 81-0571538 (State or ot ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2021 Results Conference Call March 30, 2022 4:30 PM ET Company Participants Stan Jacot - President and CEO Pam Haley - CFO Conference Call Participants Ben Klieve - Lake Street Capital Operator Good afternoon, and welcome to Arcadia Biosciences Fourth Quarter Year-end 2021 Earnings Conference Call. Today’s presenters will be Stan Jacot, President and CEO; and Pam Haley, Chief Financial Officer of Arcadia. This call is being webcast, and you can refer to the Company ...

NOVEMBER 2021 ARCADIA BIOSCIENCES INVESTOR PRESENTATION FORWARD LOOKING STATEMENTS • "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to components of the company's long-term financial success; the company's traits, commercial products, and collaborations; the company's ability to manage the regulatory processes for its traits and commercial products; the ...

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Matt Plavan – President and Chief Executive Officer Pam Haley – Chief Financial Officer Conference Call Participants Ryan Meyers – Lake Street Capital Operator Good afternoon, and welcome to Arcadia Biosciences Third Quarter 2021 Earnings Conference Call. Today’s presenters will be Matt Plavan, President and CEO; and Pam Haley, Chief Financial Officer of Arcadia. This call is being webc ...